GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Senhwa Biosciences Inc (ROCO:6492) » Definitions » General and Admin. Expense

Senhwa Biosciences (ROCO:6492) General and Admin. Expense : NT$63.11 Mil (TTM As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Senhwa Biosciences General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Senhwa Biosciences's General and Admin. Expense for the three months ended in Mar. 2025 was NT$16.59 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2025 was NT$63.11 Mil.

Senhwa Biosciences General and Admin. Expense Historical Data

The historical data trend for Senhwa Biosciences's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senhwa Biosciences General and Admin. Expense Chart

Senhwa Biosciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 83.24 71.17 43.77 54.79 62.93

Senhwa Biosciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.41 19.04 14.18 13.30 16.59

Senhwa Biosciences General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$63.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Senhwa Biosciences General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Senhwa Biosciences's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Senhwa Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Senhwa Biosciences Inc (ROCO:6492) » Definitions » General and Admin. Expense
Comparable Companies
TPE:1733 ROCO:6864 ROCO:4911 ROCO:6926 TPE:6885 ROCO:6986 ROCO:7808 ROCO:4169 ROCO:6634 ROCO:6580 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Peihsin Road, 10th Floor, No. 225, Section 3, Hsintien District, New Taipei, TWN, 23143
Website
https://www.senhwabio.com
Senhwa Biosciences Inc is engaged in the development of new drugs and special pharmaceutical ingredients focusing on human efficacy. The company's product pipeline includes Pidnarulex (CX-5461), Silmitasertib (CX-4945), and Silmitasertib (for Moderate Covid-19). All of its revenue comes from Taiwan.

Senhwa Biosciences Headlines

No Headlines